Advisors

AKLRD’s business model is led by a small group of executives accessing expert opinion to guide product development.

These advisors are recognised experts in their field and used extensively to guide AKLRD’s preclinical and clinical strategy.

Preclinical:
Prof. Frank Bonner

Former Director of Science & Technology, Huntingdon Life Sciences. Former President of British Toxicology Society

Manufacturing:
John McCrerie

Former Technical Director of Becpharm Limited; Senior Manager and International QA Director Wellcome Glaxo

AKL4 (aka APPA) Collaborators:
Dr Andy Cross
University of Liverpool, Research Associate Musculoskeletal Biology
Professor Ian Clark
University of East Anglia, Musculoskeletal Biology

AKL1 (aka TAKL) Collaborators:
Dr. Kees Beukelman
University of Utrecht, Pharmaceutical Sciences
Professor Mike Thomas
University of Southampton, Primary Care Research